Titre:
  • Risk-based decision-making in the treatment of HER2-positive early breast cancer: Recommendations based on the current state of knowledge
Auteur:Jackisch, Christian; Cortazar, Patricia; Geyer Jr., Charles C.E.; Gianni, Luca; Gligorov, Joseph; Machackova, Zuzana; Perez, Edith A; Schneeweiss, Andreas; Tolaney, Sara S.M.; Untch, Michael; Wardley, Andrew; Piccart-Gebhart, Martine
Informations sur la publication:Cancer treatment reviews, 99, 102229
Statut de publication:Publié, 2021-09
Sujet CREF:Imagerie médicale, radiologie, tomographie
Cancérologie
Mots-clés:HER2-postive early breast cancer
Neoadjuvant therapy
Neratinib
Pertuzumab
T-DM1
Trastuzumab
Note générale:SCOPUS: re.j
Langue:Anglais
Identificateurs:urn:issn:0305-7372
info:doi/10.1016/j.ctrv.2021.102229
info:pii/S0305737221000773
info:scp/85107715800